« Medarex and Compugen Collaborates to Develop Antibody-Based Therapeutics | Main | MediVas Signed Collaboration Agreement With Pfizer »

Jan25
Roche’s ACTEMRA™ (tocilizumab) Passed Phase III Study in Rheumatoid Arthritis Patients

OPTION (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial is the first international Phase III study of Roche’s ACTEMRA™ outside of Japan.

Results of which as announced by Roche, has shown that the study has successfully met its primary endpoint in patients with moderate to severe rheumatoid arthritis (RA) who had an inadequate response to methotrexate (a current standard of care).

Actemra.jpgThe study showed that a greater proportion of RA patients treated with ACTEMRA™ (either 4mg/kg or 8mg/kg) plus methotrexate achieved a significant improvement in disease signs and symptoms (ACR20) at week 24, compared with placebo plus methotrexate.

The study confirmed the safety profile of ACTEMRA™ as demonstrated in previous studies.

Not currently approved in the United States, ACTEMRA™ is the first humanized interleukin-6 (IL-6) receptor-blocking monoclonal antibody with a novel mechanism of action: reduce inflammation of the joints, prevent long-term damage and relieve certain systemic effects of RA such as anemia, fatigue and osteoporosis.

Find more details from the press release.

[Photo Credit: Chugai-Pharm]


0 Comments/Trackbacks




submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Medarex and Compugen Collaborates to Develop Antibody-Based Therapeutics | Main | MediVas Signed Collaboration Agreement With Pfizer »

Advertise

Watch the Digital Health Revolution


Related Resources

recent comments

    sponsored ads



    subscribe


    Prefer Email?
    Subscribe below-

    Enter your Email:


    Powered by FeedBlitz What's this?

    Current News

    Support This Blog

    blogroll


    top blogs

    business social media

    Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

    BIZZlogos - Add your logo - free link to your site
    BIZZphotos - Add photos of your products and people
    BIZZprofiles - Submit your profile and build your online visibility
    BIZZspotlight - Spotlight your business with free links
    BIZZvideos - Videos about businesses, products and business people.
    BIZZbites - "Digg" for Business - Submit your articles and posts

    Know More Media - Health Care / Pharmaceutical / Fitness

    know more media network

    View Network Map

    Network Feed List (OPML)

    Know More Media Network
    Feed


    we support unitus

    PRWeb

    Influencer



    PharmaGazette is a member of the Know More Media network of business related blogs.

    Here are some current headlines from some of our business publications:

    ProductivityGoal

    CallCenterScript

    AdHurl

    TheBizofKnowledge

    LandingTheDeal

    CustomersAreAlways

    HealthCareVox

    BrainBasedBusiness

    TheInsurancePolicy

    MarketingBlurb